Proud to share our new preprint on improving DNA-damaging cancer therapies through minor spliceosome inhibition. Treatments must be not only effective, but kinder. Grateful for the support. 🤍 www.biorxiv.org/content/10.6...
#minorspliceosome #breastcancer #prostatecancer #U6atac #RNAsplicing

“If opportunity doesn’t knock, build a door.” – Milton Berle

@rahulkanadia.bsky.social ky.social, @marubin1.bsky.social and I have launched Verintas Therapeutics Inc.
to target the minor spliceosome in cancer.
Thanks to Nextwave X Partners-our 1st investor and believer.
#Verintas #minorspliceosome

In cancer research, we chase the “untreatable” — but making current treatments more tolerable matters too. Grateful to the SwissLife Jubiläumsstiftung for supporting my work on minor spliceosome-based co-treatments to ease side effects and improve outcomes.
#swisslife #minorspliceosome #RNAbaseddrug

:)

We will put forward a 500 million package for 2025-2027 to make Europe a magnet for researchers.

As well as ambitious proposals for R&I in the next EU budget.

We will also offer the best and brightest the right incentives to come to Europe ↓

Bluesky is the place for science.